<- Go Home
Carl Zeiss Meditec AG
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics, as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of ZEISS Group.
Market Cap
EUR 3.8B
Volume
204.0K
Cash and Equivalents
N/A
EBITDA
EUR 226.5M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
EUR 1.1B
Profit Margin
52.00%
52 Week High
EUR 71.65
52 Week Low
EUR 39.90
Dividend
1.40%
Price / Book Value
1.80
Price / Earnings
24.98
Price / Tangible Book Value
9.63
Enterprise Value
EUR 4.3B
Enterprise Value / EBITDA
17.27
Operating Income
EUR 176.9M
Return on Equity
N/A
Return on Assets
N/A
Cash and Short Term Investments
EUR 26.6M
Debt
EUR 594.8M
Equity
EUR 2.1B
Revenue
EUR 2.2B
Unlevered FCF
N/A
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium